Monday, May 16, 2022

US FDA News: FDA Provides New Updates on Activities to Mitigate Infant Formula Supply Challenges, Abbott Nutrition Agrees to Take Corrective Actions at Facility to Produce Safe Infant Formula

Under the proposed consent decree, Abbott has agreed to take corrective actions following an FDA inspection of its Sturgis, Michigan, facility.
Read more: FDA Provides New Updates on Activities to Mitigate Infant Formula Supply Challenges, Abbott Nutrition Agrees to Take Corrective Actions at Facility to Produce Safe Infant Formula